FDA recommends new rules for cannabidiol products
The FDA has suggested new regulations for the use of cannabidiol products, as the existing rules on food and supplements were insufficient for.
Drugs
Health
Pharma
Drugs
Pharma
Jazz Pharma says cannabis-based drug aids epilepsy treatment
Jazz Pharmaceuticals Plc announced its plant-derived cannabis epilepsy medicine had improved patients' seizure and non-seizure outcomes.